by CyberKnife Miami | Oct 14, 2018 | Uncategorized
Accuray (NSDQ:ARAY) today released data from two studies of its CyberKnife stereotactic body radiotherapy device exploring its use in treating patients with low and intermediate-risk prostate cancer, touting high survival rates and minimal toxicity. The Sunnyvale,...
by CyberKnife Miami | Oct 3, 2018 | Uncategorized
This study reports on a large, multi-institutional series of patients with liver metastasis treated with CyberKnife or Stereotactic Body Radiation Therapy (SBRT) resulting in reasonable overall survival and local control were observed. Abstract BACKGROUND:...
by CyberKnife Miami | Oct 1, 2018 | Uncategorized
When it comes to cancer treatment centers in Miami patients have options. Dr. Mark Pomper, Medical Director at the CyberKnife Center of Miami explains why patients undergoing radiation therapy should consider being treated at CyberKnife Miami. Click here to watch the...
by CyberKnife Miami | Sep 18, 2018 | Uncategorized
Definitive radiotherapy for prostate cancer (PCa), even high-risk cases, is effective long-term, Australian researchers concluded. After a median follow-up of 92 months (maximum 163.8 months), the 8-year overall survival rates and biochemical relapse-free survival...
by CyberKnife Miami | Sep 10, 2018 | Uncategorized
Hormonal Imbalance – Indication of Pituitary Gland Tumors Improper functioning of the Pituitary gland usually results in excess or under production of hormones that leads to a formation of mass called tumor, which can be benign or malignant. Such tumors in this...